New Radiopharmaceutical Tools in Imaging

Area of Science:

• Nuclear Medicine
• Radiopharmaceutical Chemistry
• Molecular Imaging

Background:

• Nuclear Medicine imaging relies on radioactive probes, but their application is limited by physiological and chemical constraints.
• Factors like metabolism, lipophilicity, and chemical stability restrict the utility of many potential imaging agents.
• These limitations affect both centrally and peripherally targeted imaging compounds.

Purpose of the Study:

• To summarize existing limitations for nuclear medicine imaging probes.
• To review established and novel approaches for overcoming these constraints.
• To introduce lipid nanoparticles as a potential new delivery system for radioligands.

Main Methods:

• Review of current literature on imaging probe limitations and solutions.
• Discussion of established techniques to enhance probe performance.
• Presentation of a novel 'Trojan horse' concept using lipid nanoparticles.

Main Results:

• Identified key physiological and compound-related limitations impacting probe development.
• Highlighted various strategies to overcome these challenges in nuclear medicine.
• Proposed lipid nanoparticles as a promising, unexplored carrier system for radioligands.

Conclusions:

• Overcoming probe limitations is crucial for advancing nuclear medicine imaging.
• Established methods offer solutions, while novel approaches like lipid nanoparticle delivery show future potential.
• Lipid nanoparticles may serve as effective carrier systems, analogous to their role in conventional drug development.